Skip to main content

Search
News

EPO Hormone Improves their Outcome

|

EPO Hormone Improves their Outcome

May 20, 2014

http://www.pregnancyandbaby.com/baby/articles/967699/new-study-being-conducted-to-better-the-lives-of-preemies

 

Source - SheKnows


Seattle Children’s neonatologist Dr. Sandra Juul has been studying the effects of erythropoietin on preemies for 19 years — and she believes it is the key to combating the negative effects of extreme early births. Between 40 and 50 percent of extremely preterm infants — those born between 24 and 28 weeks of gestation — die or have moderate to severe neurodevelopmental impairment. According to Dr. Juul, these impairments can include cerebral palsy, mental impairment, blindness and deafness. Juul believes that erythropoietin (Epo), a hormone that is produced in the brain and kidneys and is essential for baby's survival, is the key to improving the lives of preterm babies because it has the ability to protect cells in the body. Based on her many years of research, she believes that Epo can be used to protect babies' brains from neurodevelopmental damage cause by extreme early delivery. Epo is currently used in a lower dose to treat or prevent anemia in preterm babies because it stimulates red blood cell production and can also reduce the need for blood transfusions. Dr. Juul and her team are currently in the process of enrolling preterm babies for her study, dubbed the PENUT Trial. The trial has 5 percent of its goal of 940 preterm infants, though enrollment just recently began.

Contact Information for Press

If you have not worked with Seattle Children’s before, please read our press policy before contacting us.

The best way to reach the public relations team is via email at press@seattlechildrens.org. This inbox is monitored seven days a week, during and after business hours, on weekends and on holidays.

Phone: 206-987-4500
(8:30 a.m. to 5:30 p.m. Pacific time, Monday–Friday only)

Note: This contact information is for members of the media only. For general hospital or research questions, please call the hospital switchboard at 206-987-2000.

Latest News

Vaccine Safety: Getting the Message to Parents in Doubt
8.28.14 — U.S. News & World Report

Measles, mumps and whooping cough have been around a long time – along with the vaccines to prevent them. But instead of being ... cont.

Depressed Teens May Need Extra Support To Stick With Treatment
8.27.14 — NPR

A new study from Seattle Children’s Research Institute suggests integrating mental health treatment into primary care may ... cont.

Can running cure depression? Seattle Children’s brain research finds exercise can help patients
8.26.14 — Puget Sound Business Journal

Researchers at Seattle Children’s Research Institute have pinpointed a tiny area of the brain that controls our motivation to ... cont.